A 38-year-old man presents with recurrent nephrolithiasis and a family history of early-onset hyperparathyroidism. Genetic testing confirms MEN1 syndrome. Which is the most common site of parathyroid involvement in MEN1?

Explanation

## Parathyroid Involvement in MEN1 **Key Point:** In MEN1 syndrome, parathyroid hyperplasia is the most common endocrine manifestation, occurring in >90% of patients by age 50. ### Anatomical Pattern of Involvement The **inferior parathyroid glands** are the most commonly and most severely affected in MEN1-associated hyperparathyroidism. This follows a pattern of differential gland involvement: | Parathyroid Gland | Frequency of Involvement | Severity | |---|---|---| | Inferior glands | Most common (earliest) | Most severe hyperplasia | | Superior glands | Common | Moderate hyperplasia | | Ectopic sites | Less common | Variable | | Carcinoma | Rare (<1%) | N/A | **Clinical Pearl:** The inferior parathyroids (derived from the third pharyngeal pouch) tend to undergo more aggressive hyperplasia in MEN1, likely due to clonal expansion from loss of the MEN1 tumor suppressor gene. This asymmetric involvement is a hallmark feature distinguishing MEN1 hyperparathyroidism from sporadic primary hyperparathyroidism, where all four glands are typically equally enlarged. ### Why Inferior Glands? 1. **Embryologic basis**: Inferior parathyroids migrate farther during development and may have different growth factor sensitivity 2. **Clonal expansion**: MEN1 mutations lead to loss of menin (a tumor suppressor), causing preferential proliferation in inferior glands 3. **Clinical consequence**: Bilateral subtotal parathyroidectomy or total parathyroidectomy with autotransplantation is often required **High-Yield:** Hyperparathyroidism is the **first manifestation** of MEN1 in most patients (present by age 20–25 in ~90% of MEN1 carriers) and is the leading cause of morbidity in MEN1. ### Ectopic Parathyroid Tissue While ectopic parathyroid tissue (mediastinal, thymic) can occur in MEN1, it is less common than inferior gland hyperplasia and is usually a secondary finding after subtotal resection of the main glands. **Warning:** Parathyroid carcinoma is extremely rare in MEN1 (<1% of cases) and should raise suspicion for other syndromes (e.g., hyperparathyroidism-jaw tumor syndrome with CDC73 mutations).